Machelle Sanders, Director: Biocryst Pharmaceuticals BCRX Sell · Filed 25/11/17

Trade details

Type: Insider sale
Amount: $68,544
Shares · price: 9,600 sh · $7.14 a share
Held after: 30,642 sh
Stock: Biocryst Pharmaceuticals BCRX
Person: Machelle SandersDirector
Trade date: 25/11/13
Filed: 25/11/17
Days to filing: 4 days

Sold 23.9% of holdings

Share of holding sold: 23.9%

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/10/14~25/12/13

Machelle Sanders's recent trades

Machelle SandersDirector
Planned saleFortrea Holdings
Planned sale
Fortrea Holdings
FTRE
$174.7K
9,700 sh
$174.7K
Filed 08/03
Traded 08/03
Machelle SandersDirector
Planned sale10b5-1 planBiocryst Pharmaceuticals
Planned sale10b5-1 plan
Biocryst Pharmaceuticals
BCRX
$68.5K
9,600 sh
$68.5K
Filed 25/11/13
Traded 25/11/13
Machelle SandersDirector
SellBiocryst Pharmaceuticals
Sell
Biocryst Pharmaceuticals
BCRX
$28.1K
4,689 sh
$28.1K
Filed 24/06/17
Traded 24/06/17
Machelle SandersDirector
SellNovan
Sell
Novan
NOVN
$4,737
11,553 sh
$4,737
Filed 23/06/27
Traded 23/06/27
Machelle SandersDirector
SellBiocryst Pharmaceuticals
Sell
Biocryst Pharmaceuticals
BCRX
$31.9K
4,000 sh
$31.9K
Filed 23/06/15
Traded 23/06/15

Machelle Sanders, Director — sold $68.5K of Biocryst Pharmaceuticals BCRX · 23.9% of holdings · 10b5-1 plan | Whalegun